SCIENTIFIC BASIS OF ‘LAW OF SIMILIA’ IN MODERN PHARMACOLOGY
Authors
DOI:
https://doi.org/10.59939/3048-6270.2024.v2.i4.2Keywords:
Homoeopathy, Similia, Cardinal Principle of Homoeopathy, PharmacologyAbstract
The Law of Similia, the foundational principle of homoeopathy, posits that substances causing symptoms in healthy individuals can be used in small doses to treat similar symptoms in patients. Introduced by Dr Samuel Hahnemann in 1796, this principle was supported by his observations of biphasic drug action: an initial primary action followed by a secondary, opposing response from the organism. This biphasic nature, conceptualized by Hahnemann, aligns closely with the rebound or paradoxical effects observed in conventional pharmacology, where drugs like anticoagulants, diuretics, and analgesics exhibit secondary responses post-administration, often opposite in nature to their therapeutic effects. Modern pharmacology’s rebound effect can be seen as a physiological response aiming to restore homeostasis, aligning with Hahnemann’s view that the body initiates a secondary counteraction to re-establish balance. This study examines the scientific foundation for therapeutic similitude by evaluating parallels between homoeopathy and the biphasic action of drugs in modern pharmacology. By establishing a link between homoeopathic principle and the physiological basis of drug actions, the study supports the relevance of therapeutic similitude, suggesting a shared scientific foundation between homoeopathy and modern medicine. The study proposes new therapeutic options through the integration of modern pharmacological insights into homoeopathy. This study highlights challenges in aligning homeopathy's individualized approach with pharmacology's standardized frameworks, paving the way for integrative medical research.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This article is Open Accessible and licensed under a Creative Commons Attribution NonCommercial 4.0 International License. You are welcome to use this work non-commercially as long as author is credited by citing the work.